Center-Authored Papers

Filters: Author is Carlson, Jonathan M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R et al..  2012.  Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity.. Journal of virology. 86(12):6913-23. Abstract
D
Dommaraju K, Kijak G, Carlson JM, Larsen BB, Tovanabutra S, Geraghty DE, Deng W, Maust BS, Edlefsen PT, Sanders-Buell E et al..  2014.  CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.. PloS one. 9(10):e111334. Abstract
E
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, Decamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS computational biology. 11(2):e1003973. Abstract
P
Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PIW, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M et al..  2010.  The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.. Science (New York, N.Y.). 330(6010):1551-7. Abstract
R
Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, Decamp AC, Carrico C, Menis S, Magaret CA et al..  2012.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.. Nature. 490(7420):417-20. Abstract
S
Sunshine J, Kim M, Carlson JM, Heckerman D, Czartoski J, Migueles SA, Maenza J, McElrath MJ, Mullins JI, Frahm N.  2014.  Increased Sequence Coverage through Combined Targeting of Variant and Conserved Epitopes Correlates with Control of HIV Replication.. Journal of virology. 88(2):1354-65. Abstract